Citywide Colon Cancer Control Coalition (C5)

Colon cancer (also called colorectal cancer) is cancer that occurs in the colon or rectum. It affects men and women of all racial and ethnic groups, and is most often found in people aged 50 years or older. In the United States, it is the third most common cancer for men and women and is the second leading cause of cancer-related deaths. In 2013, 1,329 New Yorkers died of colon cancer. Preventing or finding cancer early can save your life! Screening is important BEFORE symptoms occur because colon cancers and polyps (abnormal growths) often do not show symptoms.

C5 helps New York City attain colon cancer control goals through advocacy, resource development, and policy initiatives.

The New York City Department of Health and Mental Hygiene convened the Citywide Colon Cancer Control Coalition in March of 2003. The mission of C5 is to increase awareness and screening for colorectal cancer in New York City in order to reduce the incidence and mortality of the disease. In order to achieve our mission, C5 strengthens DOHMH’s colon cancer prevention efforts through advocacy, resource development, policy initiatives, community leadership, strategic planning, and by facilitating communication between the DOHMH and the key stakeholders. Since its inception, C5 has been a critical partner in NYC’s efforts to control colon cancer. This prestigious multi-stakeholder coalition includes dedicated and talented health professionals, clinicians, researchers, academics, administrators and advocates from various public and private institutions and organizations.

New York City has witnessed an increase in screening rates in recent years, from 42% in 2003 to 70% in 2014. Additionally, racial and ethnic colon cancer screening disparities among Blacks, Whites, Hispanics and Asians have been eliminated. C5 has been a key element of NYC’s success.

C5 continues to strengthen the DOHMH colon cancer prevention and control efforts through the work of its various committees, workgroups, and initiatives.

For more information about Colon Cancer and the C5, please visit the DOHMH website.